Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease

Abstract

Plasma tau is higher in AD independently from CSF-tau. Importantly, adding plasma tau to CSF tau or P-tau improves diagnostic accuracy, suggesting that plasma tau may represent a useful biomarker for AD, especially when added to CSF tau measures.